Name: RAPT Therapeutics, Inc. (RAPT) Balance Sheet
Creator: FinSpry

RAPT Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for RAPT Therapeutics, Inc. (RAPT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	169.74	47.48	38.95	189.65	111.51	77.38
Short-Term Investments	61.32	111.38	210.12	165.63	86.59	0.00
Cash & Short-Term Investments	231.06	158.86	249.07	189.65	111.51	77.38
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	4.18	2.92	3.63	4.43	2.29	1.75
Total Current Assets	235.24	161.78	252.69	192.97	115.60	80.51
Non-Current Assets
Property, Plant & Equipment (Net)	4.70	7.68	9.48	2.74	2.98	3.71
Other Non-Current Assets	0.39	3.87	4.04	2.92	0.39	0.39
Total Non-Current Assets	5.09	11.55	13.52	5.66	3.37	4.10
Total Assets	240.33	173.33	266.21	198.64	118.97	84.60
Current Liabilities
Accounts Payable	1.28	5.18	3.37	8.33	7.32	4.79
Short-Term Debt	2.42	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	44.60	14.10	8.66	2.67	4.94	0.00
Deferred Revenue	0.00	0.00	0.00	1.02	4.10	0.00
Other Current Liabilities	0.06	0.11	0.03	0.25	0.33	0.47
Total Current Liabilities	48.35	21.84	14.22	9.60	11.74	9.26
Non-Current Liabilities
Long-Term Debt	2.07	4.46	6.82	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	2.15	2.19	0.00
Total Non-Current Liabilities	2.07	4.46	6.82	2.66	3.05	2.23
Total Liabilities	50.42	26.29	21.04	12.26	14.79	11.48
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-614.55	-484.68	-367.88	-284.25	-215.02	-161.95
Accumulated Other Comprehensive Income	0.05	0.10	-0.03	-0.21	-0.18	0.02
Additional Paid-in Capital	804.39	631.61	613.07	470.63	319.20	235.05
Shares Outstanding	16.50	4.30	4.28	3.69	0.00	0.00
Total Stockholders' Equity	189.90	147.04	245.17	186.38	104.18	73.12
Total Liabilities & Equity	240.33	173.33	266.21	198.64	118.97	84.60